---
title: "The Cigna Group (CI.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/CI.US.md"
symbol: "CI.US"
name: "The Cigna Group"
industry: "Health Care Services"
datetime: "2026-04-14T08:18:01.305Z"
locales:
  - [en](https://longbridge.com/en/quote/CI.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/CI.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/CI.US.md)
---

# The Cigna Group (CI.US)

## Company Overview

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. It operates through two segments: Evernorth Health Services and Cigna Healthcare. The Evernorth Health Services segment includes Pharmacy Benefit Services and Specialty and Care Services, offering pharmacy benefit management, drug claim adjudication, retail pharmacy network administration, benefit design consultation, drug utilization review, drug formulary management, pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty pharmaceutical distribution, and clinical programs for whole-person health outcomes. The Cigna Healthcare segment comprises U.S.

| Item | Detail |
|------|--------|
| Industry | Health Care Services |
| Exchange | US Market |
| Website | [www.thecignagroup.com](https://www.thecignagroup.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: B
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-04-14T04:30:18.000Z

**Overall: B (0.38)**

**Industry**: Health Care Services

| Metric | Value |
|--------|-------|
| Industry Ranking | 1 / 89 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Large - The company has stable operations, allowing for dependable long-term returns.

**Multi Score**: B

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 11.24% |  |
| Net Profit YoY | 73.47% |  |
| P/B Ratio | 1.74 |  |
| Dividend Ratio | 2.21% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 72484215680.00 |  |
| Revenue | 274900000000.00 |  |

#### Multi Score Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 14.40% | B |
| Profit Margin | 2.17% | C |
| Gross Margin | 9.30% | E |
| Revenue YoY | 11.24% | B |
| Net Profit YoY | 73.47% | A |
| Total Assets YoY | 1.31% | C |
| Net Assets YoY | 1.53% | C |
| Cash Flow Margin | 161.17% | B |
| OCF YoY | 11.24% | B |
| Turnover | 1.75 | A |
| Gearing Ratio | 73.48% | D |

```chart-data:radar
{
  "title": "Longbridge Financial Score - The Cigna Group",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "11.24%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "73.47%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "1.74",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "2.21%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "72484215680.00",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "274900000000.00",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "B",
      "indicators": [
        {
          "name": "ROE",
          "value": "14.40%",
          "rating": "B"
        },
        {
          "name": "Profit Margin",
          "value": "2.17%",
          "rating": "C"
        },
        {
          "name": "Gross Margin",
          "value": "9.30%",
          "rating": "E"
        },
        {
          "name": "Revenue YoY",
          "value": "11.24%",
          "rating": "B"
        },
        {
          "name": "Net Profit YoY",
          "value": "73.47%",
          "rating": "A"
        },
        {
          "name": "Total Assets YoY",
          "value": "1.31%",
          "rating": "C"
        },
        {
          "name": "Net Assets YoY",
          "value": "1.53%",
          "rating": "C"
        },
        {
          "name": "Cash Flow Margin",
          "value": "161.17%",
          "rating": "B"
        },
        {
          "name": "OCF YoY",
          "value": "11.24%",
          "rating": "B"
        },
        {
          "name": "Turnover",
          "value": "1.75",
          "rating": "A"
        },
        {
          "name": "Gearing Ratio",
          "value": "73.48%",
          "rating": "D"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 12.17 | 6/89 | 16.56 | 15.27 | 11.90 |
| PB | 1.74 | 23/89 | 2.07 | 1.91 | 1.74 |
| PS (TTM) | 0.26 | 11/89 | 0.33 | 0.29 | 0.27 |
| Dividend Yield | 2.21% | 6/89 | 2.21% | 2.06% | 1.86% |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Cigna (CI.US) | B | B | A | D | B | B |
| 02 | BrightSpring Health Services - Unit (BTSGU.US) | C | A | A | D | A | B |
| 03 | Fresenius (FSNUY.US) | C | B | C | C | B | B |
| 04 | Labcorp (LH.US) | B | C | B | C | B | B |
| 05 | Quest Diagnostics (DGX.US) | B | B | B | C | B | B |

## Institutional View

### Analyst Rating Distribution

> As of 2026-04-10T04:00:00.000Z

Total Analysts: **25**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 16 | 64% |
| Overweight | 6 | 24% |
| Hold | 3 | 12% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 275.12 |
| Highest Target | 378.00 |
| Lowest Target | 290.00 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/CI.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/CI.US/norm.md)
- [Related News](https://longbridge.com/en/quote/CI.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/CI.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**